Cargando…

Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes

Ectosomes (Ects) are a subpopulation of extracellular vesicles formed by the process of plasma membrane shedding. In the present study, we profiled ectosome-specific microRNAs (miRNAs) in patients with type 2 diabetes mellitus (T2DM) and analyzed their pro- and anti-angiogenic potential. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Stępień, Ewa Ł., Durak-Kozica, Martyna, Kamińska, Agnieszka, Targosz-Korecka, Marta, Libera, Marcin, Tylko, Grzegorz, Opalińska, Agnieszka, Kapusta, Maria, Solnica, Bogdan, Georgescu, Adriana, Costa, Marina C., Czyżewska-Buczyńska, Agnieszka, Witkiewicz, Wojciech, Małecki, Maciej T., Enguita, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071541/
https://www.ncbi.nlm.nih.gov/pubmed/30083267
http://dx.doi.org/10.7150/thno.23334
Descripción
Sumario:Ectosomes (Ects) are a subpopulation of extracellular vesicles formed by the process of plasma membrane shedding. In the present study, we profiled ectosome-specific microRNAs (miRNAs) in patients with type 2 diabetes mellitus (T2DM) and analyzed their pro- and anti-angiogenic potential. Methods: We used different approaches for detecting and enumerating Ects, including atomic force microscopy, cryogenic transmission electron microscopy, and nanoparticle tracking analysis. Furthermore, we used bioinformatics tools to analyze functional data obtained from specific miRNA enrichment signatures during angiogenesis and vasculature development. Results: Levels of miR-193b-3p, miR-199a-3p, miR-20a-3p, miR-26b-5p, miR-30b-5p, miR-30c-5p, miR-374a-5p, miR-409-3p, and miR-95-3p were significantly different between Ects obtained from patients with T2DM and those obtained from healthy controls. Conclusion: Our results showed differences in the abundance of pro- and anti-angiogenic miRNAs in Ects of patients with T2DM, and are suggestive of mechanisms underlying the development of vascular complications due to impaired angiogenesis in such patients.